Matt Schwartz
About Matt Schwartz
Matt Schwartz is the Director of Cell Therapy Drug Product Process Development at Bristol Myers Squibb in Warren, New Jersey, with extensive experience in cell culture process development and technology transfer.
Current Role at Bristol Myers Squibb
Matt Schwartz currently serves as the Director of Cell Therapy Drug Product Process Development at Bristol Myers Squibb in Warren, New Jersey, United States. In this role, he oversees the development of cell therapy drug products, contributing his extensive experience in cell culture process development, technology transfer, and GMP compliance to the company's innovative treatments.
Previous Positions at Celgene
Prior to his current role, Matt Schwartz worked at Celgene, where he held multiple positions. From 2019 to 2021, he was the Director of Cell Culture Process Development in New Jersey. Before that, he served as Associate Director for 11 months in Summit, New Jersey. Earlier, he worked as a Senior Scientist for 11 months, also in Summit. His tenure at Celgene contributed significantly to his expertise in cell culture and process development.
Career at Eli Lilly and ImClone Systems
Matt Schwartz has an extensive history with Eli Lilly and its subsidiary ImClone Systems. At Eli Lilly, he worked as a Research Engineer in Cell Culture Process Development from 2016 to 2017 in Branchburg, NJ. At ImClone Systems, he held multiple roles, including Manager, Principal Associate, and Scientist in Cell Culture Process Development, spanning from 2009 to 2016. These positions provided him with a deep understanding of cell culture processes and technology transfer.
Educational Background in Biotechnology and Biology
Matt Schwartz has a robust educational background that supports his career in biotechnology. He earned a Master's of Science in Biotechnology from Kean University, where he studied from 2006 to 2008. He also holds a Bachelor of Science in Biology from Penn State University, completed between 1999 and 2003. This academic foundation has been critical in his development and expertise in cell culture and process development.
Skills and Expertise in the Biotechnology Industry
Matt Schwartz possesses extensive experience and skills in the biotechnology industry, particularly in cell culture process development. He has a strong background in technology transfer and GMP compliance, which are crucial for scaling up cell therapy processes. Additionally, he is skilled in data analysis, essential for optimizing cell therapy drug product processes. His demonstrated history in the field showcases a robust understanding of biopharmaceutical manufacturing and process development.